• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用潜在类别分析诊断异基因造血干细胞移植后血清标志物移植物抗宿主病。

Application of latent class analysis in diagnosis of graft-versus-host disease by serum markers after allogeneic haematopoietic stem cell transplantation.

机构信息

Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Proteomics Research Center and Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Sci Rep. 2020 Feb 27;10(1):3633. doi: 10.1038/s41598-020-60524-2.

DOI:10.1038/s41598-020-60524-2
PMID:32108153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7046680/
Abstract

Graft-versus-host disease (GVHD) is one of the major causes of morbidity and mortality in 25-70% of patients. The gold standard (GS) test to confirm the diagnosis of GVHD has some limitations. The current study was conducted to evaluate the accuracy of three serum markers in diagnosing GVHD without a GS. 94 patients who were hospitalized for allogeneic transplantation were studied. Mean levels from day of haematopoietic stem cell transplantation (HSCT) to discharge of serum uric acid (UA), lactate dehydrogenase (LDH), and creatinine (Cr) were measured for all participants. We adapted a Bayesian latent class analysis to modelling the results of each marker and combination of markers. The Sensitivity, Specificity, and area under receiver operating characteristic curve (AUC) for LDH were as 51%, 81%, and 0.70, respectively. For UA, the Sensitivity, Specificity, and AUC were 54%, 75%, and 0.71, respectively. The estimated Sensitivity, Specificity, and AUC of Cr were 72%, 94%, and 0.86, respectively. Adjusting for covariates, the combined Sensitivity, Specificity, and AUC of the optimal marker combination were 76%, 83%, and 0.94, respectively. To conclude, our findings suggested that Cr had the strongest diagnosis power for GVHD. Moreover, the classification accuracy of the three-marker combination outperforms the other combinations.

摘要

移植物抗宿主病(GVHD)是导致 25-70%患者发病和死亡的主要原因之一。GVHD 确诊的金标准(GS)检测存在一定局限性。本研究旨在评估在无 GS 的情况下,三种血清标志物诊断 GVHD 的准确性。对因异基因移植而住院的 94 例患者进行了研究。对所有参与者,从造血干细胞移植(HSCT)当天到出院,测量血清尿酸(UA)、乳酸脱氢酶(LDH)和肌酐(Cr)的平均水平。我们采用贝叶斯潜在类别分析对每种标志物和标志物组合的结果进行建模。LDH 的灵敏度、特异性和接受者操作特征曲线(ROC)下面积(AUC)分别为 51%、81%和 0.70。UA 的灵敏度、特异性和 AUC 分别为 54%、75%和 0.71。Cr 的估计灵敏度、特异性和 AUC 分别为 72%、94%和 0.86。调整协变量后,最佳标志物组合的联合灵敏度、特异性和 AUC 分别为 76%、83%和 0.94。总之,我们的研究结果表明,Cr 对 GVHD 具有最强的诊断能力。此外,三种标志物组合的分类准确性优于其他组合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/553e/7046680/fdeb3b584432/41598_2020_60524_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/553e/7046680/525cb7ff3bee/41598_2020_60524_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/553e/7046680/fdeb3b584432/41598_2020_60524_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/553e/7046680/525cb7ff3bee/41598_2020_60524_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/553e/7046680/fdeb3b584432/41598_2020_60524_Fig2_HTML.jpg

相似文献

1
Application of latent class analysis in diagnosis of graft-versus-host disease by serum markers after allogeneic haematopoietic stem cell transplantation.应用潜在类别分析诊断异基因造血干细胞移植后血清标志物移植物抗宿主病。
Sci Rep. 2020 Feb 27;10(1):3633. doi: 10.1038/s41598-020-60524-2.
2
The role of serum uric acid in the prediction of graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.血清尿酸在异基因造血干细胞移植中预测移植物抗宿主病的作用。
J Clin Lab Anal. 2020 Jul;34(7):e23271. doi: 10.1002/jcla.23271. Epub 2020 Mar 2.
3
Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.用于预测去T细胞异基因干细胞移植后急性移植物抗宿主病严重程度及诊断的复合生物标志物面板——单中心初步研究
J Clin Pathol. 2017 Oct;70(10):886-890. doi: 10.1136/jclinpath-2017-204399. Epub 2017 Apr 27.
4
Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study.肿瘤致瘤性2早期抑制对异基因干细胞移植后急性移植物抗宿主病及移植相关并发症的预测价值:前瞻性观察研究
Turk J Haematol. 2020 Feb 20;37(1):20-29. doi: 10.4274/tjh.galenos.2019.2019.0139. Epub 2019 Aug 29.
5
Association between low uric acid levels and acute graft-versus-host disease.低尿酸水平与急性移植物抗宿主病之间的关联。
Ann Hematol. 2015 Jan;94(1):139-44. doi: 10.1007/s00277-014-2180-3. Epub 2014 Aug 31.
6
Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.尿酸氧化酶在降低清髓性异基因干细胞移植后急性移植物抗宿主病中的I期研究。
Biol Blood Marrow Transplant. 2014 May;20(5):730-4. doi: 10.1016/j.bbmt.2014.02.003. Epub 2014 Feb 12.
7
Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM).血清胆碱酯酶是移植物抗宿主病(GVHD)和移植相关死亡率(TRM)的早期敏感标志物。
Bone Marrow Transplant. 2001 Dec;28(11):1041-5. doi: 10.1038/sj.bmt.1703281.
8
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation.造血干细胞移植患儿移植物抗宿主病发病时的血浆3型 pentraxin 水平可预测疾病严重程度及对治疗的反应。
Oncotarget. 2016 Dec 13;7(50):82123-82138. doi: 10.18632/oncotarget.13488.
9
Changes in protein serum levels during stem cell transplantation.干细胞移植过程中血清蛋白水平的变化。
Eur J Clin Invest. 2017 Oct;47(10):711-718. doi: 10.1111/eci.12796. Epub 2017 Sep 5.
10
Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后代谢生物标志物预测急性移植物抗宿主病和复发。
JCI Insight. 2018 May 3;3(9):99672. doi: 10.1172/jci.insight.99672.

引用本文的文献

1
An Intelligent Clinical Decision Support System for Predicting Acute Graft-versus-host Disease (aGvHD) following Allogeneic Hematopoietic Stem Cell Transplantation.一种用于预测异基因造血干细胞移植后急性移植物抗宿主病(aGvHD)的智能临床决策支持系统。
J Biomed Phys Eng. 2021 Jun 1;11(3):345-356. doi: 10.31661/jbpe.v0i0.2012-1244. eCollection 2021 Jun.

本文引用的文献

1
Biomarkers in Graft-Versus-Host Disease: from Prediction and Diagnosis to Insights into Complex Graft/Host Interactions.移植物抗宿主病的生物标志物:从预测和诊断到深入了解复杂的移植物/宿主相互作用。
Curr Hematol Malig Rep. 2018 Feb;13(1):44-52. doi: 10.1007/s11899-018-0433-2.
2
EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis.急性移植物抗宿主病患者的EASIX:一项回顾性队列分析。
Lancet Haematol. 2017 Sep;4(9):e414-e423. doi: 10.1016/S2352-3026(17)30108-4. Epub 2017 Jul 18.
3
Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
移植物抗宿主病的预测:基于淋巴细胞和细胞因子的生物标志物组合
Ann Hematol. 2017 Jul;96(7):1127-1133. doi: 10.1007/s00277-017-2999-5. Epub 2017 Apr 26.
4
Combining biomarkers for classification with covariate adjustment.结合生物标志物进行分类并进行协变量调整。
Stat Med. 2017 Jul 10;36(15):2347-2362. doi: 10.1002/sim.7274. Epub 2017 Mar 9.
5
Classification systems for chronic graft-versus-host disease.慢性移植物抗宿主病的分类系统。
Blood. 2017 Jan 5;129(1):30-37. doi: 10.1182/blood-2016-07-686642. Epub 2016 Nov 7.
6
Changes in serum uric acid levels after allogeneic hematologic stem cell transplantation: A retrospective cohort study.异基因造血干细胞移植后血清尿酸水平的变化:一项回顾性队列研究。
Blood Res. 2016 Sep;51(3):200-203. doi: 10.5045/br.2016.51.3.200. Epub 2016 Sep 23.
7
Graft-versus-host disease management.移植物抗宿主病的管理
Bratisl Lek Listy. 2016;117(7):388-96. doi: 10.4149/bll_2016_077.
8
Biomarker Panel for Chronic Graft-Versus-Host Disease.慢性移植物抗宿主病的生物标志物组合
J Clin Oncol. 2016 Aug 1;34(22):2583-90. doi: 10.1200/JCO.2015.65.9615. Epub 2016 May 23.
9
Soluble heat shock protein 70 members in patients undergoing allogeneic hematopoietic cell transplantation.接受异基因造血细胞移植患者中的可溶性热休克蛋白70成员
Transpl Immunol. 2016 May;36:25-31. doi: 10.1016/j.trim.2016.03.003. Epub 2016 Mar 25.
10
Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?抗胸腺细胞球蛋白在白消安/氟达拉滨预处理方案用于匹配相关供者造血干细胞移植中是否有一席之地?
Korean J Intern Med. 2016 Jul;31(4):750-61. doi: 10.3904/kjim.2015.234. Epub 2016 Mar 28.